Guggenheim Capital’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-59,186
| Closed | -$3.3M | – | 2282 |
|
|
2018
Q4 | $3.3M | Buy |
59,186
+14,148
| +31% | +$768K | 0.03% | 777 |
|
|
2018
Q3 | $2.09M | Buy |
45,038
+6,561
| +17% | +$317K | 0.01% | 1217 |
|
|
2018
Q2 | $1.86M | Buy |
38,477
+7,612
| +25% | +$364K | 0.01% | 1297 |
|
|
2018
Q1 | $1.34M | Buy |
30,865
+6,640
| +27% | +$298K | ﹤0.01% | 1914 |
|
|
2017
Q4 | $962K | Buy |
24,225
+3,720
| +18% | +$155K | ﹤0.01% | 2098 |
|
|
2017
Q3 | $890K | Buy |
20,505
+8,941
| +77% | +$408K | ﹤0.01% | 2151 |
|
|
2017
Q2 | $554K | Sell |
11,564
-830
| -7% | -$38.7K | ﹤0.01% | 2369 |
|
|
2017
Q1 | $508K | Buy |
12,394
+3,133
| +34% | +$131K | ﹤0.01% | 2374 |
|
|
2016
Q4 | $355K | Sell |
9,261
-386
| -4% | -$15.7K | ﹤0.01% | 2537 |
|
|
2016
Q3 | $518K | Buy |
9,647
+1,801
| +23% | +$83.6K | ﹤0.01% | 2373 |
|
|
2016
Q2 | $337K | Buy |
7,846
+2,116
| +37% | +$88.8K | ﹤0.01% | 2509 |
|
|
2016
Q1 | $290K | Buy |
+5,730
| New | +$276K | ﹤0.01% | 2567 |
|
Guggenheim Capital's IMPV Position: Q1 2019 in Review
Guggenheim Capital sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 59,186 shares — an estimated $3.3M sold.
Guggenheim Capital first reported a position in IMPV in Q1 2016 and held it in 12 quarters. The position peaked at $3.3M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Guggenheim Capital reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Guggenheim Capital sold 59,186 Imperva, Inc. shares in Q1 2019, an estimated $3.3M.
- Guggenheim Capital first reported a position in Imperva, Inc. in Q1 2016 and held it in 12 quarters.
- Guggenheim Capital's Imperva, Inc. position peaked at $3.3M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Guggenheim Capital's 13F filing for Q1 2019, filed 15 May 2019.